pharmacie et médicaments – Délai d'accès aux nouveaux médicaments

This written question asks about the timeline for accessing new medicines in France. It highlights concerns regarding the speed at which innovative treatments become available to patients. The question seeks to understand the factors influencing drug approval and reimbursement processes, and their impact on public health and patient well-being.